Erytech Pharma - Spon ADRPHXM
13F holders, Q1 2024 (March 31)1holders
$2.50avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Erytech Pharma - Spon ADR (PHXM) in their 13F filings. The largest holder was Asset Dedication, LLC ($1K).
- Company
- Erytech Pharma - Spon ADR
- CUSIP
- 29604W207
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $0 |
Ownership 1 holders
| Asset Dedication, LLC | 0.00% | No change | 400 | $1K |
"% of holder's portfolio" is PHXM's weight in each manager's 13F, not the share of Erytech Pharma - Spon ADR the manager owns.